Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. on November 1, 2020. The filing reports on the status of the Company's Annual General Meeting of Shareholders originally convened on this date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements.
Material Changes
No material financial changes were reported. The primary event noted is the adjournment of the Annual General Meeting of Shareholders due to a lack of quorum.
Outlook, Risks, and Management Commentary
Management has scheduled a reconvened Annual General Meeting for Sunday, November 8, 2020, at 2:00 p.m. Israel Standard Time. The meeting will be held at the offices of the Company's legal counsel, Doron, Tikotzky, Kantor, Gutman, Nass, Amit Gross and Co., located at B.S.R 4 Tower, 33rd Floor, 7 Metsada Street, Bnei Brak. No specific risks, contingencies, or unusual items were disclosed in this text.
Key Facts for Investors to Verify
- The original Annual General Meeting on November 1, 2020, failed to achieve a quorum.
- The meeting has been rescheduled for November 8, 2020.
- Shareholders should verify the location and time of the reconvened meeting to ensure participation.
- Financial performance data is not included in this specific filing.